DESIRED OUTCOMES & GOALS OF TREATMENT:
Management of the patient with OA begins with a diagnosis based on a careful
history, physical examination, radiographic findings, and an assessment of the
extent of joint involvement.
GENERAL APPROACH TO TREATMENT:
Treatment for each OA patient depends on the distribution and severity of joint
involvement, comorbid disease states, concomitant medications, and allergies.
3
GOALS
To educate the
patient,
caregivers,
and relatives
To maintain
or improve
joint mobility
To limit
functional
impairment
To relieve
pain and
stiffness
To maintain
or improve
quality
of life
4
TREATMENT
Non pharmacological
treatment / non drug
therapy.
Pharmacological / drug
therapy.
Surgery
•Arthroscopic
lavage.
•Cartilage repair.
•Osteotomy.
•Arthroplasty.
•Diet
•Physical &
occupational
therapy.
•Surgery.
•Oral analgesics
•Topical analgesics
•Nutritional
supplement.
•NSAIDS
•Hyalouronic acid
products.
5
Symptomatic pain acetaminophen topical therapy
Symptomatic pain & inflammation NSAIDS (or) COX-2
Risk for GI
Ulceration
& bleeding
CV risk or risk
for GI events
Chronic kidney
disease
sub therapeutic
response to NSAIDS
or celecoxib
Celecoxib + PPI
(or) misoprostol
Non selective
+ PPI (or)
Misoprostol
(or) tramadol
Tramadol (or)
Intra articular
injections
Naproxen +
PPI (or)
misoprostol
Tramadol
6
MEDICATION BRAND NAME DOSE &
FREQUENCY
ORAL ANALGESICS
Acetaminophen TYLENOL 350-650 mg every 4-6 hours
(or) 1g 3-4 times/day.
Tramadol COMBITRAM,
ANATRAM
50-100 every 4-6 hours.
TOPICAL ANALGESICS
Capsaicin 0.025% (or)
0.075%
CAPZASIN, ZOSTRIX Apply to affected joint 3-4
times per day.
NUTRITIONAL
SUPPLEMENTS
Glucosamino sulfate GENICIN 500 mg 3 times/ day (or)
1500 mg once daily
7
MEDICATION BRAND NAME DOSE &
FREQUENCY
NSAID’S
1.)CARBOXYLIC ACIDS
a.)Acetylated salicylates
Aspirin (plain buffered (or)
enteric coated
BAYER 325-650 mg every 4-6 hours
for pain, anti inflammatory
doses start at 3600mg/day in
divided doses.
b.)Non acetylated salicylates
Salsalate DISALCID 500-1000mg 2-3 times a day
Choline magnesium
salicylate
TRILISATE 500-1000mg 2-3 times a day
8
MEDICATION BRAND NAME DOSE & FREQUENCY
2.)ACETIC ACIDS
Diclofenac VOLTAREN 100-150 mg/day in divided
doses
Indomethacin INDOCIN 25 mg 2-3 times a day, 75
mg sustained release once
daily
Ketorolac TORADOL 10 mg every 4-6 hours
Nabumetone RELAFEN 500-1000 mg 1-2 times a
day
3.)PROPIONIC ACID
Ibuprofen ADVIL 1200-3200 mg/day in 3-4
divided doses
Ketoprofen ACTRON 150-300 mg/day in 3-4
divided doses
Naproxen ALEVE, MIDOL 250-500 mg twice a day
10
DRUGS ADVERSE DRUG REACTIONS
Acetaminophen Hepatotoxicity-increased in patients with
excessive alcohol intake(>3 drinks per day)
Non selective cox-1,2 inhibitors. GI:
Epigastric distress,nausea & vomiting
Gastric & duodenal ulceration
GIT perforation & bleeding
Selective cox-2 inhibitors Increase of cardiovascular event (thrombosis)
Opioid analgesics Nausea, somnolence, constipation &
dizziness
Tramadol Dizziness, vertigo, nausea, vomiting,
constipation & lethargy.
11
DRUGS ADVERSE DRUG REACTIONS
Glucosamine & Chondroitin Glucosamine: mild GIT symptoms like
bloating & cramps.
Chondroitin: Nausea
Corticosteroids Flushing, acute inflammatory reaction after
injection atrophy of subcutaneous tissues &
local skin depigmentation may occur
Hyaluronic acid Local reactions, post injection flares &
anaphylaxis (rare)
Capsaicin Burning, stinging, and/or erythema
12
13
PROPHYLAXIS OF OSTEOARTHRITIS:
By age 65, more than half of us will have x-ray evidence of osteoarthritis.
Here are 4 steps you can take now to prevent osteoarthritis or its
progression.
1)CONTROL WEIGHT.
2)EXERCISE.
3)AVOID INJURIES OR GET THEM TREATED.
4)EAT RIGHT.
Omega-3 fatty acids.
Vitamin-C.
Vitamin-D.
14
15
CONTROL WEIGHT:
•NHANES ( National Health & Nutrition Examination Survey) studies showed
that obese women were nearly 4 times more likely to have osteoarthritis compared
to non-obese women.The risk for obese men was nearly 5 times greater than for
non-obese men.
•In study of osteoarthritis in a population in Framingham, mass researches
estimated that overweight women who lost 11 pounds or about 2 BMI points
decreased their risk of osteoarthritis by more than 50%.
EXERCISE:
•The safest exercises are those that place the least body weight on the joints , such
as bicycling, swimming & other water exercise.Light weight lifting is another
potion.
AVOID INJURIES OR GET THEM TREATED:
•Suffering with a joint injury when you are young predisposes you to
osteoarthritis in the same joint when you are older.
People who injured their knee as an adult had a 5 times greater risk of
osteoarthritis in the joint.
EAT RIGHT:
Although no specific diet has been shown to prevent osteoarthritis, certain
nutrients have been associated with a reduced risk of the disease or its
severity. They include:
Omega-3 fatty acids: These healthy fats reduce joint inflammation.Good
sources of omega-3 fatty acids include:
Fish oils & certain plant/nut oils, including walnut, canola, soyabean,
flaxseed/linseed & olive.
Vitamin-C: Intake of vitamin-C (120-200 mg/day) reduced the risk of
osteoarthritis progression threefold.
16
You can get more vit.C in your diet by eating green pepper, citrus fruits &
juices, white strawberries, tomatoes, broccoli, turnip greens & other leafy
greens, sweet & potatoes & cantaloupe.
Vitamin-D: Framingham study participants showed that people who have
knee osteoarthritis & low blood levels of vitamin-D are 3 times more likely to
experience disease progression, compared to people with high levels of the
vitamin.
Your body makes most of the vit.D it needs in response to sunlight.
You can get more vit.D in your diet by eating fatty fish such as salmon,
mackerel, tuna, sardines & herring, vit-D fortified milk & cereal & eggs.
17
18
19
REFERENCES:
RODGER WALKER, CATE WHITTLESEA; Treatment & prophylaxis of
osteoarthritis; Clinical pharmacy & Therapeutics; 5
th
Edition; p.g.no: 843-845
ERIC. T. HERFINDAL, DICK R. GOURLEY, HART; Treatment &
prophylaxis of osteoarthritis; Clinical pharmacy & Therapeutics; 4
th
Edition;
p.g.no: 727-738
BRAIN K. ALLDREDGE, ROBIN L. CORELLI, MICHAEL E. ERNST;
Treatment & prophylaxis of osteoarthritis; Koda – kimble & Young’s applied
therapeutics, The clinical use of Drugs, 10
th
Edition, p.g.no: 990-1000
JOSEPH T. DIPIRO et.al; Treatment & prophylaxis of osteoarthritis;
Pharmacotherapy A Pathophysiologic approach; 6
th
edition; p.g.no: 1685-1700